Clik here to view.
Masimo SpHb®による新生児の非侵襲的・連続的ヘモグロビン測定の精度を究明する新研究
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ: MASI）は本日、Journal of Tropical Pediatrics誌に最近掲載された研究にて、新生児患者に対するMasimo...
View ArticleClik here to view.
Merck’s KEYTRUDA® (pembrolizumab) Receives Two New Approvals in Japan
KENILWORTH, N.J. Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that KEYTRUDA, Merck’s anti-PD-1 therapy, has received two new approvals from the Japan...
View ArticleClik here to view.
Bio-Thera Solutions and BeiGene Announce License, Distribution, and Supply...
GUANGZHOU & BEIJING & CAMBRIDGE, Mass Bio-Thera Solutions, Ltd., a commercial stage biopharmaceutical company (688177.SH) and BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), today announced that...
View ArticleClik here to view.
Clik here to view.
Clik here to view.
BeiGene Appoints Corsee Sanders, Ph.D. to its Board of Directors
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
Kubota Vision Completes POC Clinical Study Using Wearable Myopia Control...
SEATTLE Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced the...
View ArticleClik here to view.
Nanox Announces Closing of Initial Public Offering and Full Exercise of...
NEVE ILAN, Israel NANO-X IMAGING LTD (“Nanox” or the “Company”), an innovative medical imaging technology company, announced today the closing of its initial public offering of 10,555,556 ordinary...
View ArticleClik here to view.
拓臻生物任命Senthil Sundaram为首席执行官、Mark Vignola, Ph.D.为首席财务官、Erin Quirk, M.D.为总裁
加州福斯特城 (美国商业资讯)–拓臻生物（Terns Pharmaceuticals, Inc.）是一家生物制药公司，专注于开发治疗肝病的同类最佳单药和联合用药。公司今天宣布，任命Senthil Sundaram为首席执行官(CEO)兼董事、Mark Vignola, Ph.D.为首席财务官。此外，2019年1月加入拓臻生物担任首席医学官的Erin Quirk,...
View ArticleClik here to view.
Modalis Therapeutics Reports Second Quarter 2020 Financial Results and...
TOKYO & CAMBRIDGE, Mass. Modalis Therapeutics Corporation (Modalis) (TOKYO: 4883), a leading company developing innovative products for the treatment of rare genetic diseases utilizing its...
View ArticleClik here to view.
Astex Pharmaceuticals Announces That Tolinapant (ASTX660), a Novel Antagonist...
PLEASANTON, Calif. Astex Pharmaceuticals, Inc., a wholly owned subsidiary of Otsuka Pharmaceutical Co., Ltd., based in Tokyo, Japan, announces that the US Food & Drug Administration (FDA) has...
View ArticleClik here to view.
MEDIROM Announces Discovery of Disease Factors via Lifestyle DataBase x AI...
TOKYO Revorf Co., Ltd. and MEDIROM Healthcare Technologies Inc. are pleased to announce that they have entered into a business collaboration agreement as of September 1st, 2020. This press release...
View ArticleClik here to view.
Promega Launches Spectrum Compact CE Benchtop DNA Analysis Instrument with...
MADISON, Wis. Promega today launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech. The personal CE system...
View ArticleClik here to view.
LUCA Science Announces $9.8 Million Series A Financing to Support Research...
TOKYO LUCA Science, a company developing functional mitochondria as therapeutic agents, an emerging platform to treat damaged tissues and organs, today announced the closing of a $9.8 million Series...
View ArticleClik here to view.
私人集团 RLS (USA) Inc.收购GE医疗的美国放射性药房网络
佛罗里达州坦帕 (美国商业资讯)–RLS (USA) Inc.(Radioisotope Life Sciences)已收购通用电气(GE)的美国放射性药房网络，成为美国最大的专注于纯分子成像的公司。全球性精品金融咨询公司Capitor (www.capitor.co)精心构建该交易并将其带给投资者，在各方历经数年的谈判与协作中发挥了关键作用。财务条款未披露。...
View ArticleClik here to view.
Clik here to view.
Regent Pacific to Acquire Longevity AI Startup Deep Longevity for HK$29.56...
HONG KONG Deep Longevity, Inc (“DLI”), a leader in artificial intelligence for aging and longevity research, announced that it has entered into an agreement to be acquired for a potential...
View ArticleClik here to view.
Shionogi Granted New Technology Add-on Payment For FETROJA® (Cefiderocol) by CMS
OSAKA, Japan and FLORHAM PARK, N.J. Shionogi & Co., Ltd. (hereafter “Shionogi”) today announces that the Centers for Medicare & Medicaid Services (CMS) has granted a new technology add-on...
View ArticleClik here to view.
BeiGene Announces Inclusion of Its Shares in the Shanghai-Hong Kong and...
BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today...
View ArticleClik here to view.
Chennai Boy Undergoes First of Its Kind Living Donor Liver Transplant in...
CHENNAI, India A 16 years old boy from Chennai who was suffering from decompensated chronic liver disease due to ‘Cholesteryl ester storage disease’, has undergone successful liver transplant at...
View Article